Uncategorized

Guggenheim Maintains a Buy Rating on Eli Lilly and Company (LLY), Sets a $875 PT

Eli Lilly and Company (NYSE:LLY) is one of the best stocks to invest in for the long term. In a report released on August 13, Seamus Fernandez from Guggenheim maintained a Buy rating on Eli Lilly and Company (NYSE:LLY) and set a price target of $875.00. The rating update came after Eli Lilly and Company […]